A862 15 mg (Methylphenidate Hydrochloride Extended-Release 15 mg)
Pill with imprint A862 15 mg is Yellow & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 15 mg. It is supplied by Actavis Pharma, Inc..
Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for A862 15 mg
Methylphenidate Hydrochloride Extended-Release
- Imprint
- A862 15 mg
- Strength
- 15 mg
- Color
- Yellow & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3862
More about methylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 852 Reviews
- Drug class: CNS stimulants
- FDA Alerts (3)
Consumer resources
- Methylphenidate
- Methylphenidate transdermal
- Methylphenidate Oral, Transdermal (Advanced Reading)
- Methylphenidate Transdermal (Advanced Reading)
- Methylphenidate Controlled-Release Tablets
- ... +9 more
Other brands: Concerta, Ritalin, Quillivant XR, Jornay PM, ... +11 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
